Morgan Stanley Rockwell Medical, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Morgan Stanley holds 11,022 shares of RMTI stock, worth $24,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,022

Previous 10,703 2.98%

Holding current value

$24,909

Previous $18,000 138.89%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.67 - $4.4 $532 - $1,403	319 Added 2.98%	11,022 $43,000
Q2 2024 Oct 17, 2024	SELL	$1.45 - $1.92 $10,045 - $13,301	-6,928 Reduced 39.29%	10,703 $18,000
Q2 2024 Aug 14, 2024	SELL	$1.45 - $1.92 $10,045 - $13,301	-6,928 Reduced 39.29%	10,703 $18,000
Q1 2024 Oct 17, 2024	BUY	$1.23 - $1.86 $8,521 - $12,886	6,928 Added 64.73%	17,631 $29,000
Q1 2024 Aug 16, 2024	SELL	$1.23 - $1.86 $10,863 - $16,427	-8,832 Reduced 33.37%	17,631 $29,000
Q1 2024 May 15, 2024	SELL	$1.23 - $1.86 $10,863 - $16,427	-8,832 Reduced 33.37%	17,631 $29,000
Q4 2023 Aug 16, 2024	BUY	$1.58 - $2.44 $24,900 - $38,454	15,760 Added 147.25%	26,463 $50,000
Q4 2023 Feb 13, 2024	SELL	$1.58 - $2.44 $11,843 - $18,290	-7,496 Reduced 22.07%	26,463 $50,000
Q3 2023 Nov 15, 2023	BUY	$1.83 - $6.19 $40,135 - $135,759	21,932 Added 182.36%	33,959 $70,000
Q2 2023 Aug 14, 2023	BUY	$1.8 - $5.46 $851 - $2,582	473 Added 4.09%	12,027 $65,000
Q1 2023 May 15, 2023	SELL	$1.03 - $2.62 $1,608 - $4,092	-1,562 Reduced 11.91%	11,554 $20,000
Q4 2022 Feb 14, 2023	SELL	$0.84 - $1.39 $165 - $273	-197 Reduced 1.48%	13,116 $13,000
Q3 2022 Nov 14, 2022	BUY	$1.2 - $2.11 $67 - $118	56 Added 0.42%	13,313 $17,000
Q2 2022 Aug 15, 2022	BUY	$1.28 - $4.84 $16,968 - $64,163	13,257 New	13,257 $17,000

Others Institutions Holding RMTI

# of Institutions

Shares Held

9.46M

Call Options Held

339K

Put Options Held

43.3K

View Full List

About ROCKWELL MEDICAL, INC.

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $24.1M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

More about RMTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account